Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
C
Cell Bio Human Tech Co Ltd
KOSDAQ:318160
Cell Bio Human Tech Co Ltd
KOSDAQ:318160
Price:
6 650
KRW
-2.78%
Market Closed
Market Cap:
₩62.1B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
C
|
Cell Bio Human Tech Co Ltd
KOSDAQ:318160
|
KR |
|
D
|
Digital Network SA
WSE:DIG
|
PL |
|
E
|
Energy World Corporation Ltd
OTC:EWCLF
|
AU |
|
D
|
Denali Therapeutics Inc
F:4DN
|
US |
|
M
|
Mercury Systems Inc
F:MCY
|
US |
|
M
|
Megachem Thailand PCL
SET:MGT
|
TH |
|
A
|
Adtran Networks SE
DUS:ADV
|
DE |
|
A
|
ais AG
DUS:LUM
|
DE |
|
R8 Capital Investments PLC
LSE:MODE
|
UK |
|
M
|
MakinaRocks Co Ltd
KOSDAQ:477850
|
KR |
|
E
|
Everbright Digital Holding Ltd
NASDAQ:EDHL
|
HK |
|
A
|
Advance ZincTek Ltd
F:BBJ
|
AU |
|
Frontera Energy Corp
OTC:FECCF
|
CA |
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is Cell Bio Human Tech Co Ltd's stock price target?
Not Available
Cell Bio Human Tech Co Ltd does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Cell Bio Human Tech Co Ltd?
Projected CAGR
23%
23%
Over the last 6 years, the compound annual growth rate for Revenue has been 13%. The projected CAGR for the next 1 year is 23%.
What is the Operating Income forecast for Cell Bio Human Tech Co Ltd?
Projected CAGR
63%
63%
Over the last 6 years, the compound annual growth rate for Operating Income has been 12%. The projected CAGR for the next 1 year is 63%.